- Abstract:
-
The CCAAT enhancer binding protein alpha (C/EBPalpha) is an important myeloid tumor suppressor that is frequently mutated in human acute myeloid leukemia (AML). We have previously shown that mice homozygous for the E2F repression-deficient Cebpa(BRM2) allele develop nonfatal AML with long latency and incomplete penetrance, suggesting that accumulation of secondary mutations is necessary for disease progression. Here, we use SRS19-6-driven retroviral insertional mutagenesis to compare the phen...
Expand abstract - Journal:
- Blood
- Volume:
- 111
- Issue:
- 8
- Pages:
- 4309-4321
- Publication date:
- 2008-04-05
- DOI:
- EISSN:
-
1528-0020
- ISSN:
-
0006-4971
- URN:
-
uuid:84b504d1-67cc-4de2-ad4c-e4535e892b25
- Source identifiers:
-
324063
- Local pid:
- pubs:324063
- Language:
- English
- Keywords:
- Copyright date:
- 2008
Journal article
Mutation of C/EBPalpha predisposes to the development of myeloid leukemia in a retroviral insertional mutagenesis screen.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record